328 results on '"Soddu, Silvia"'
Search Results
2. AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway
3. SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
4. Combined alteration of lamin and nuclear morphology influences the localization of the tumor-associated factor AKTIP
5. Inactivation of HIPK2 attenuates KRASG12D activity and prevents pancreatic tumorigenesis.
6. The Cockayne syndrome group A and B proteins are part of a ubiquitin–proteasome degradation complex regulating cell division
7. The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer
8. Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties
9. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers
10. p53 mitotic centrosome localization preserves centrosome integrity and works as sensor for the mitotic surveillance pathway
11. p53 Regulates Myogenesis by Triggering the Differentiation Activity of pRb
12. p53 Inhibits α6β4 Integrin Survival Signaling by Promoting the Caspase 3-Dependent Cleavage of AKT/PKB
13. HIPK2 and extrachromosomal histone H2B are separately recruited by Aurora-B for cytokinesis
14. Interference with p53 Protein Inhibits Hematopoietic and Muscle Differentiation
15. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
16. Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation
17. Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia‐Telangiectasia Mutated Gene
18. Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue
19. Effects of Y361‐auto‐phosphorylation on structural plasticity of the HIPK2 kinase domain
20. MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors
21. Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
22. Additional file 1 of SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
23. HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression
24. Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia-Telangiectasia Mutated Gene.
25. Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
26. P53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes
27. Mutant cohesin drives chromosomal instability in early colorectal adenomas
28. Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene
29. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
30. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2
31. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2
32. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage
33. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function
34. Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy
35. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G 2/M checkpoint
36. Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras
37. Development of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy
38. The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells
39. Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation
40. HIPK2 Is Required for Midbody Remnant Removal Through Autophagy-Mediated Degradation
41. An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis
42. HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis
43. Extrachromosomal Histone H2B Contributes to the Formation of the Abscission Site for Cell Division
44. p53 Inhibits (Alpha)6(Beta)4 Integrin Survival Signaling by Promoting the Caspase 3-dependent Cleavage of AKT/PK
45. Oncogenes belonging to the CSF-1 transduction pathway direct p53 tumor suppressor effects to monocytic differentiation in 32D cells
46. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells
47. Additional file 3: of Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
48. Additional file 7: of Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
49. Additional file 10: of Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
50. Additional file 5: of Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.